Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of cyclosporine A on insulin secretion in kidney transplant candidates
2004-004488-31Phase 4Active
- Sponsor
- Rikshospitalet
- Start
- Feb 2005
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, single-arm trial of cyclosporine in end-stage kidney disease (ESKD), kidney failure and Kidney allograft status (RTx), sponsored by Rikshospitalet. Primary endpoint: Change in insulin secretion. Started Feb 2005; status: active.
02
Drugs
cyclosporine
03
Conditions
end-stage kidney disease (ESKD)kidney failureKidney allograft status (RTx)
Beyond the preview
Go deeper on 2004-004488-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004488-31.